L. Musu

发表

Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis

G. Fenu, J. Frau, E. Cocco, 2019, Journal of Neurology.

Association between the ancestral haplotype HLA A30B18DR3 and multiple sclerosis in central Sardinia

D. Clayton, L. Bernardinelli, C. Montomoli, 2001, Genetic epidemiology.

Risk for Relatives of Patients with Multiple Sclerosis in Central Sardinia, Italy

L. Bernardinelli, I. Prokopenko, C. Montomoli, 2003, Neuroepidemiology.

Multiple sclerosis recurrence risk for siblings in an isolated population of Central Sardinia, Italy

L. Bernardinelli, I. Prokopenko, S. Seaman, 2002, Genetic epidemiology.

Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

D. Centonze, C. Pozzilli, L. Grimaldi, 2014, Neurological Sciences.

Association between the ACCN1 Gene and Multiple Sclerosis in Central East Sardinia

D. Cox, L. Bernardinelli, I. Prokopenko, 2007, PloS one.

Walking improvements with nabiximols in patients with multiple sclerosis

M. Pau, G. Fenu, J. Frau, 2015, Journal of Neurology.

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

L. Grimaldi, A. Gallo, M. C. Buscarinu, 2018, Journal of Neurology.

Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case–control MRI study

G. Fenu, J. Frau, M. Marrosu, 2018, Journal of Neurology.

Influence of treatments in multiple sclerosis disability: A cohort study

P. Contu, G. Fenu, J. Frau, 2015, Multiple sclerosis.

An Ecologic Study of Geographical Variation in Multiple Sclerosis Risk in Central Sardinia, Italy

L. Bernardinelli, C. Montomoli, C. Allemani, 2002, Neuroepidemiology.

Epidemiology of multiple sclerosis in south-western Sardinia

Claudia Sardu, Paolo Contu, Nicola Carboni, 2011, Multiple sclerosis.